Evidence map›Paper›PMID 37791112›Full record

ArticleGynecologic oncology reports2023

A comparative analysis of endometrial cancer disparities in incidence, mortality, and survival between women living in Puerto Rico, Non-Hispanic Blacks, Non-Hispanic Whites, and US Hispanics between 2000-2018.

Ana Rosario-Santos, Carlos R Torres-Cintrón, Ana G López-Rexach, Paulina Gonzalez-Carcache, Guillermo Tortolero-Luna, Sharee Umpierre

Abstract read
In one paragraph

Article in Gynecologic oncology reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ana Rosario-SantosUniversity of Puerto Rico School of Medicine, Gynecologic Oncology Division of Obstetrics and Gynecology Department, United States.
Carlos R Torres-CintrónUniversity of Puerto Rico, Comprehensive Cancer Center. Puerto Rico Central Cancer Registry, United States.
Ana G López-RexachUniversity of Puerto Rico School of Medicine, Gynecologic Oncology Division of Obstetrics and Gynecology Department, United States.
Paulina Gonzalez-CarcacheUniversity of Puerto Rico School of Medicine, Gynecologic Oncology Division of Obstetrics and Gynecology Department, United States.
Guillermo Tortolero-LunaUniversity of Puerto Rico, Comprehensive Cancer Center. Puerto Rico Central Cancer Registry, United States.
Sharee UmpierreUniversity of Puerto Rico School of Medicine, Obstetrics and Gynecology Department, Gynecologic Oncology Division, United States.

Funding

UPR School of Medicine Endowed Health Services Research*S21MD000242 · NIMHD · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI FRONTERA, WALTER R · 2002 to 2004
$15.0M
UPR School of Medicine Program for Research ExcellenceS21MD000138 · NIMHD · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI JOGLAR, FRANCISCO M · 2002 to 2002
$2.9M
NIMHD NIH HHS S21 MD000138NIMHD NIH HHS S21 MD000242
6 · The paper itself

Abstract

Objective: Endometrial cancer diagnosis in younger women is increasing in Puerto Rico and the United States. The study aims to evaluate the endometrial cancer trends in incidence, mortality, and survival by comparing US ethnic groups (NHW, NHB, and Hispanic) to women living in PR to assess whether disparities exist by age and stage at diagnosis on outcomes of interest. Methods: We performed a secondary data analysis and comparison of the age-specific and age-adjusted incidence rates, mortality rates, and the survival of endometrial cancer in PR with that of NHB, NHW, and Hispanic using data from the PR Central Cancer Registry, the SEER Program, and PR Demographic Registry from 2000 to 2018. Results: PR had the highest incidence rates (41.3 per 100,000 women) of endometrial cancer, followed by NHW, NHB, and Hispanic. Women in PR younger than 65 years old had higher incidence rates of endometrial cancer than compared groups. NHB have higher overall mortality rates (12.5 per 100,000 women). Between ages 20-34 and 35-49, women in PR have the highest mortality rates, and after age 50, mortality rates are higher for NHB. Conclusions: Women in PR had higher endometrial cancer incidence rates in increasing trend from 2000 to 2018 compared to similar NHB, Hispanic, and NHW cohorts. Also, women in PR experienced higher incidence and mortality rates below 50 years old among all races and ethnicities. Future studies are needed to evaluate histology, obesity trends, and the impact on the quality of life for this cohort.

Indexed as

Endometrial cancer analysis including Puerto RicoEndometrial cancer disparities in Puerto Pico (PR)Endometrial cancer risk factorsIncreasing incidence of endometrial cancer in the US and PRSEER

Identifiers

PMID37791112
PMCPMC10542592

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.